ID   EL4.NOB-1
AC   CVCL_0257
SY   EL4NOB1; NOB-1
DR   CLO; CLO_0002918
DR   MCCL; MCC:0000148
DR   CLDB; cl1162
DR   ECACC; 87020408
DR   Wikidata; Q54832238
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NOB-1
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3819 ! EL4.BU.OU6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//